EFACC 2026 will include abstract presentations by allergists/immunologists and fellows-in-training. We encourage you to participate by submitting your clinical research findings for consideration by our Abstract Committee. In preparing your abstract, organize it into a statement of purpose, statement of methods, and summary of results in sufficient detail to support the conclusion reached.
Once your abstract is accepted for the conference, you will be assigned a poster location to present your findings. Abstracts will have the option to be published in the Journal of Food Allergy.
Fellows-in-training:
Abstract submission fee is waived for presenting an abstract and/or attending the conference.
Abstract application:
Please see form below.
Abstract Instructions:
- Poster size for display: 4 feet high by 6 feet wide.
- The abstract must adequately describe the objectives, methods, results, and conclusions so that the Abstract Committee may evaluate the quality of the work and proposed presentation.
- The abstract title should fully reflect the content of the abstract body.
- A structured abstract format is preferable; that is, all abstracts should contain these sections: Introduction (background information and purpose of the project/study), Methods (study design, techniques), Results (summary of data), and Conclusions.
- Illustrations and tables are not permitted.
- Supplementary data is not accepted under any circumstances.
- Abbreviations may be used in the abstract if such abbreviations are defined at their first mention.
- The abstract length is limited to 300 words.
- Abstracts must be submitted in a word .DOC format
- Authors are to be listed by First name, Last name, Highest degree. Affiliations are not necessary.
- Authors are encouraged, but not required, to submit for peer review and publication, any subsequent full-length manuscripts which derive from the submitted abstract to the Journal of Food Allergy (JFA). Corresponding authors may contact Managing Editor Susan Colucci for full author instructions.
- Each abstract submission must specify a corresponding author, to whom all correspondence about the abstract will be directed.
- Abstracts are submitted for poster presentation.
- The presenter of each accepted abstract must register for the scientific meeting in the standard fashion.
- Wherever possible, noncommercial (generic) names must be used in all abstracts and posters. The Editorial staff may request a revised submission of the abstract to enforce compliance with this ACCME requirement.
- All authors must agree to disclose all non-FDA approved use of FDA approved drugs during the abstract submission process as well as in the actual presentation (oral or poster).
- The authors must accept sole responsibility for the statements in their submitted abstract.
Abstract submission:
Submit abstracts to jillcourcier@easternmedicalconferences.org by December 4, 2025
Abstract Fees:
Non-commercial abstracts - no charge
Commercially funded abstracts - $400 submission only / $800 submission + publication
*Abstracts will be posted on the EFACC website at the conclusion of the conference.*